Raising the Bar for Therapeutic Trials in Advanced Prostate Cancer

被引：2
作者：
Alumkal, Joshi J. [1 ]
Beer, Tomasz M. [1 ]
机构：
[1] Oregon Hlth & Sci Univ, Portland, OR 97201 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2016年 / 34卷 / 25期
关键词：
DOCETAXEL PLUS PREDNISONE; PHASE-III TRIAL; DOUBLE-BLIND; CLINICAL-TRIALS; PLACEBO; MEN; CABOZANTINIB; MITOXANTRONE; COMBINATION;
D O I：
10.1200/JCO.2016.68.0439
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
[No abstract available]
引用
收藏
页码：2958 / +
页数：5
相关论文
共 25 条
  • [1] Why Do Phase III Clinical Trials in Oncology Fail so Often?
    Amiri-Kordestani, Laleh
    Fojo, Tito
    [J]. JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2012, 104 (08) : 568 - 569
  • [2] [Anonymous], P GEN CANC S
  • [3] Androgen Receptor Splice Variant 7 and Efficacy of Taxane Chemotherapy in Patients With Metastatic Castration-Resistant Prostate Cancer
    Antonarakis, Emmanuel S.
    Lu, Changxue
    Luber, Brandon
    Wang, Hao
    Chen, Yan
    Nakazawa, Mary
    Nadal, Rosa
    Paller, Channing J.
    Denmeade, Samuel R.
    Carducci, Michael A.
    Eisenberger, Mario A.
    Luo, Jun
    [J]. JAMA ONCOLOGY, 2015, 1 (05) : 582 - 591
  • [4] AR-V7 and Resistance to Enzalutamide and Abiraterone in Prostate Cancer
    Antonarakis, Emmanuel S.
    Lu, Changxue
    Wang, Hao
    Luber, Brandon
    Nakazawa, Mary
    Roeser, Jeffrey C.
    Chen, Yan
    Mohammad, Tabrez A.
    Chen, Yidong
    Fedor, Helen L.
    Lotan, Tamara L.
    Zheng, Qizhi
    De Marzo, Angelo M.
    Isaacs, John T.
    Isaacs, William B.
    Nadal, Rosa
    Paller, Channing J.
    Denmeade, Samuel R.
    Carducci, Michael A.
    Eisenberger, Mario A.
    Luo, Jun
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2014, 371 (11) : 1028 - 1038
  • [5] Docetaxel and dasatinib or placebo in men with metastatic castration-resistant prostate cancer (READY): a randomised, double-blind phase 3 trial
    Araujo, John C.
    Trudel, Geralyn C.
    Saad, Fred
    Armstrong, Andrew J.
    Yu, Evan Y.
    Bellmunt, Joaquim
    Wilding, George
    McCaffrey, John
    Serrano, Sergio V.
    Matveev, Vsevolod B.
    Efstathiou, Eleni
    Oudard, Stephane
    Morris, Michael J.
    Sizer, Bruce
    Goebell, Peter J.
    Heidenreich, Axel
    de Bono, Johann S.
    Begbie, Stephen
    Hong, Jun H.
    Richardet, Eduardo
    Gallardo, Enrique
    Paliwal, Prashni
    Durham, Susan
    Cheng, Shinta
    Logothetis, Christopher J.
    [J]. LANCET ONCOLOGY, 2013, 14 (13) : 1307 - 1316
  • [6] Chi KN, 2015, J CLIN ONCOL S, V33
  • [7] Castration-Resistant Prostate Cancer: AUA Guideline Amendment
    Cookson, Michael S.
    Lowrance, William T.
    Murad, Mohammad H.
    Kibel, Adam S.
    [J]. JOURNAL OF UROLOGY, 2015, 193 (02) : 491 - 499
  • [8] American Society of Clinical Oncology Perspective: Raising the Bar for Clinical Trials by Defining Clinically Meaningful Outcomes
    Ellis, Lee M.
    Bernstein, David S.
    Voest, Emile E.
    Berlin, Jordan D.
    Sargent, Daniel
    Cortazar, Patricia
    Garrett-Mayer, Elizabeth
    Herbst, Roy S.
    Lilenbaum, Rogerio C.
    Sima, Camelia
    Venook, Alan P.
    Gonen, Mithat
    Schilsky, Richard L.
    Meropol, Neal J.
    Schnipper, Lowell E.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (12) : 1277 - +
  • [9] Phase III, Randomized, Placebo-Controlled Study of Docetaxel in Combination With Zibotentan in Patients With Metastatic Castration-Resistant Prostate Cancer
    Fizazi, Karim S.
    Higano, Celestia S.
    Nelson, Joel B.
    Gleave, Martin
    Miller, Kurt
    Morris, Thomas
    Nathan, Faith E.
    McIntosh, Stuart
    Pemberton, Kristine
    Moul, Judd W.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (14) : 1740 - +
  • [10] Assumptions of Expected Benefits in Randomized Phase III Trials Evaluating Systemic Treatments for Cancer
    Gan, Hui K.
    You, Benoit
    Pond, Gregory R.
    Chen, Eric X.
    [J]. JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2012, 104 (08) : 590 - 598
123